Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography

NCT03783832 is registered in ClinicalTrials.gov with Aquitania Opthalmologica as lead sponsor.

NCT NCT03783832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography
Lead sponsor
Aquitania Opthalmologica
Phase
Observational
Overall status
Unknown status
Start date
June 19, 2018
Completion date
December 31, 2019
Enrollment
48 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema